These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase. Markianos M; Tripodianakis J; Garelis E Biol Psychiatry; 1983 Mar; 18(3):347-54. PubMed ID: 6132626 [TBL] [Abstract][Full Text] [Related]
3. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia. Baron M; Gruen R; Levitt M; Kane J Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia. Goodnick PJ; Tong C; Duncavage MB; Meltzer HY Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962 [No Abstract] [Full Text] [Related]
5. A biochemical study of tardive dyskinesia in young male patients. Jeste DV; DeLisi LE; Zalcman S; Wise CD; Phelps BH; Rosenblatt JE; Potkin SG; Bridge TP; Wyatt RJ Psychiatry Res; 1981 Jun; 4(3):327-31. PubMed ID: 6115438 [TBL] [Abstract][Full Text] [Related]
6. Serum dopamine-beta-hydroxylase activity in schizophrenia. Meltzer HY; Nasr SJ; Tong C Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516 [TBL] [Abstract][Full Text] [Related]
18. Plasma dopamine beta-hydroxylase activity in a North Swedish isolate with a high frequency of schizophrenia. Ross SB; Böök JA; Wetterberg L Clin Genet; 1981 May; 19(5):415-7. PubMed ID: 7296932 [TBL] [Abstract][Full Text] [Related]